| Fund ID | 805-4396916588 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | No |
| Annual audit | No |
| Prepared per GAAP | No |
| Sub-advised | No |
| Sales limited to qualified investors | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 77% |
| Fund | Type | Gross assets |
|---|---|---|
| Chl Investor Fund, LLC | Venture Capital | $76.1M |
| Chl I LP Series and | Venture Capital | $66.6M |
| Ch Ventures II, L.P. | Venture Capital | $61.6M |
Chl I LP Series Zbiotics reports $22,799 in gross assets, among the top 99% of private funds by size.
Chl I LP Series Zbiotics is managed by Champion Hill Labs, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.